Experimental group:Liraglutide

4 trials

Sponsors

Department of Endocrinology and Metabolism, Zhujiang Hospital, Southern Medical University, Affiliated Hospital of Guangdong Medical University, Affiliated Hospital of Guizhou Medical University, Affiliated Cancer Hospital of Chongqing University

Conditions

DiabetesHyperglycemiadiabetesnewly-diagnosed overweight / obesity type 2 diabetes mellitus

Phase 4

Glucagon-like Peptide-1 Receptor Agonists Regulating Glucose Metabolism by Regulating Intestinal Flora and its Metabolites: A Prospective, Multi-center Clinical Study.

Active, not recruitingChiCTR1900023036

Department of Endocrinology and Metabolism, Zhujiang Hospital, Southern Medical UniversityDiabetes

Start: 2019-06-01Updated: 2019-05-13

Efficacy and safety of liraglutide in the treatment of newly-diagnosed overweight / obesity type 2 diabetes mellitus: a single-center, randomized, parallel controlled trial

Active, not recruitingChiCTR1900026485

Affiliated Hospital of Guangdong Medical Universitynewly-diagnosed overweight / obesity type 2 diabetes mellitus

Start: 2020-06-01Updated: 2019-10-14

Research on the clinical efficacy and mechanism of Liraglutide in glucocorticoid-induced hyperglycemia

RecruitingChiCTR2000041308

Affiliated Hospital of Guizhou Medical UniversityHyperglycemia

Start: 2020-09-01Updated: 2021-03-08

Evaluation of the efficacy of liraglutide or glargine in type 2 diabetes patients combined with malignant tumor which treated with glucocorticoid

Active, not recruitingChiCTR2100049169

Affiliated Cancer Hospital of Chongqing Universitydiabetes

Start: 2021-09-01Updated: 2022-04-04